RecruitingPHASE2, PHASE3NCT05816382
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Studying Narcolepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Takeda
- Principal Investigator
- Study DirectorTakeda
- Intervention
- TAK-861(drug)
- Enrollment
- 500 enrolled
- Eligibility
- 16-70 years · All sexes
- Timeline
- 2023 – 2028
Study locations (30)
- Sleep Disorders Center of Alabama, Birmingham, Alabama, United States
- Stanford Center for Sleep Sciences and Medicine, Redwood City, California, United States
- SDS Clinical Trials, Inc., Santa Ana, California, United States
- Delta Waves LLC - Hunt - PPDS, Colorado Springs, Colorado, United States
- Florida Pediatric Research Institute, Orlando, Florida, United States
- Neurotrials Research, Atlanta, Georgia, United States
- Georgia Neuro Center, Gainesville, Georgia, United States
- Neurocare Inc, Newton, Massachusetts, United States
- Henry Ford Medical Center - Columbus, Novi, Michigan, United States
- Research Carolina Elite, Denver, North Carolina, United States
- ARSM Research, LLC, Huntersville, North Carolina, United States
- CTI Research Center, Cincinnati, Ohio, United States
- Intrepid Research, Cincinnati, Ohio, United States
- The Cleveland Clinic Foundation, Cleveland, Ohio, United States
- Ohio Sleep Medicine Institute, Dublin, Ohio, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05816382 on ClinicalTrials.govOther trials for Narcolepsy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07365566Pain Assessment in Patients With Idiopathic REM Sleep Behaviour DisorderUniversity Hospital, Toulouse
- RECRUITINGPHASE3NCT07363720A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyTakeda
- RECRUITINGNCT07299097Epidemiology of Narcolepsy Type 1 and Type 2 in SpainTakeda
- RECRUITINGPHASE2NCT06809803Extended-release Sodium Oxybate in ChildrenStanford University
- RECRUITINGPHASE1NCT06961266A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1Jazz Pharmaceuticals
- RECRUITINGPHASE2NCT06952699A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)Takeda
- RECRUITINGNCT06292598Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control PopulationCentre Hospitalier Universitaire de Nīmes
- RECRUITINGNANCT06797284The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake DisordersSecond Affiliated Hospital of Soochow University